ViewRay Inc (VRAYQ) Stock Price, Trades & News

ViewRay Inc designs, manufactures and markets MRIdian, an MR Image-Guided radiation therapy system to simultaneously image and treat cancer patients. MRIdian's high-definition MR was purpose-built to address specific challenges, including beam distortion, skin toxicity, and other concerns that may arise when high magnetic fields interact with radiation beams.

Financial Strength

	Name	Current	Vs Industry		Vs History

Growth Rank

	Name	Current	Vs Industry		Vs History

Momentum Rank

	Name	Current	Vs Industry		Vs History
	6-1 Month Momentum %	900
	12-1 Month Momentum %	900

Liquidity Ratio

	Name	Current	Vs Industry		Vs History

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History

Profitability Rank

	Name	Current	Vs Industry		Vs History
	FCF Margin %	-110.31
	OCF Margin %	-106.67

GF Value Rank

4/10

	Name	Current	Vs Industry		Vs History
	EV-to-Forward-Revenue	0.16
	FCF Yield %	-1685700

Financials (Next Earnings Date:2026-07-20 Est.)

Annual Quarterly TTM

VRAYQ's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Gurus Latest Trades with OTCPK:VRAYQ

No Available Data

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

ViewRay Inc Executives

Details

GF Value™

VRAYQ

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected issues with VRAYQ. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil $)	105.864
	EPS (TTM) ($)	-0.6
	Beta	2.5212
	3-Year Sharpe Ratio	0.33
	3-Year Sortino Ratio	1.74
	Volatility %	900
	14-Day RSI	-
	14-Day ATR ($)	0.000006
	20-Day SMA ($)	0.0001
	12-1 Month Momentum %	900
	52-Week Range ($)	0.000001 - 0.0001
	Shares Outstanding (Mil)	183.4

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	0
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

ViewRay Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

ViewRay Inc Stock Events

Financials Calendars

Event	Date	Price ($)
Third quarter earnings results for 2026	2026-11-09	In 116 days
Second quarter earnings results for 2026	2026-08-20	In 35 days
First quarter earnings results for 2026	2026-07-20	In 4 days
General meeting for 2025	2026-07-20	In 4 days
First quarter earnings results for 2025	2025-05-30	0.00 (+0.00%)
General meeting for 2024	2025-04-30	0.00 (+0.00%)
Annual report for 2024	2025-03-31	0.00 (+0.00%)
Fourth quarter earnings results for 2024	2025-02-28	0.00 (+0.00%)
Third quarter earnings results for 2024	2024-11-29	0.00 (+0.00%)
Second quarter earnings results for 2024	2024-10-04	0.00 (+0.00%)

Show

Entries

ViewRay Inc Frequently Asked Questions

What is ViewRay Inc(VRAYQ)'s stock price today?

The current price of VRAYQ is $0.00. The 52 week high of VRAYQ is $0.00 and 52 week low is $0.00.

When is next earnings date of ViewRay Inc(VRAYQ)?

The next earnings date of ViewRay Inc(VRAYQ) is 2026-07-20 Est..

Does ViewRay Inc(VRAYQ) pay dividends? If so, how much?

ViewRay Inc(VRAYQ) does not pay dividend.

Guru Commentaries on OTCPK:VRAYQ

No articles.

Press Release

	Subject	Date
	ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets	2023-07-21
	ViewRay® Files Voluntary Chapter 11 Petitions	2023-07-17
	VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian® MRI-Guided Radiation Therapy System	2023-06-13
	ViewRay's MRIdian® to be Featured at Leading European Radiation Oncology Meeting	2023-05-12
	ViewRay Announces First Quarter 2023 Results	2023-05-10
	ViewRay Announces Conference Call for First Quarter 2023 Financial Results to be Held After Market on May 10, 2023	2023-05-09
	ViewRay Announces Preliminary First Quarter 2023 Results and Updated Fiscal Year 2023 Financial Guidance; Company to Explore Strategic Alternatives to Maximize Shareholder Value	2023-04-13
	ViewRay Announces Conference Call for Preliminary First Quarter 2023 Financial Results to be held Pre-Market opening on April 13, 2023	2023-04-12
	Siteman Cancer Center at Washington University Treats 2,000th Patient with MRIdian® MRI-Guided Radiation Therapy	2023-03-02
	ViewRay Announces Conference Call for Fourth Quarter 2022 Financial Results to be Held After Market on February 27, 2023	2023-01-31

10/Page

Articles on ViewRay Inc

No articles.

Headlines

No news.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.